ENTG vs LRCX
Entegris, Inc. and Lam Research, both Technology
Lam Research is the larger company at $487B against $27B. On trailing earnings LRCX is the cheaper of the two at a P/E of 54.6 against 81.9, a gap that is only a bargain if the two are growing at similar rates. Over the past year LRCX returned +230% against +95% for ENTG. Ryufin's sector-relative Smart Score puts LRCX ahead, 9/10 against 4/10.
| Figure | ENTG | LRCX |
|---|---|---|
| Last close | $143 | $315 |
| Market cap | $27B | $487B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 81.9 | 54.6 |
| Dividend yield | 0.3% | 0.3% |
| 1-year return | +95% | +230% |
| 5-year return | +20% | +420% |
| Ryufin Smart Scoresector-relative, 1–10 | 4/10 | 9/10 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Entegris, Inc.
Revenue of $812M in Q1 2026, net income $92M. Its largest reported line is Advanced Purity Solutions, 57% of the disclosed total.
Lam Research
Revenue of $6.7B in Q4 2026, net income $2.3B. Its largest reported line is CN, 34% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or read the correlation.